Premium
Developments and translational relevance for the canine haematopoietic cell transplantation preclinical model
Author(s) -
Graves Scott S.,
Storb Rainer
Publication year - 2020
Publication title -
veterinary and comparative oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.864
H-Index - 34
eISSN - 1476-5829
pISSN - 1476-5810
DOI - 10.1111/vco.12608
Subject(s) - transplantation , immunosuppression , medicine , haematopoiesis , stem cell , animal model , immunology , biology , genetics
The development of safe and reliable haematopoietic cell transplantation (HCT) protocols to treat human patients with malignant and non‐malignant blood disorders was highly influenced by preclinical studies obtained in random‐bred canines. The surmounted barriers included recognizing the crucial importance of histocompatibility matching, establishing long‐term donor haematopoietic cell engraftment, preventing graft‐vs‐host disease and advancing effective conditioning and post‐grafting immunosuppression protocols, all of which were evaluated in canines. Recent studies have applied the tolerance inducing potential of HCT to solid organ and vascularized composite tissue transplantation. Several advances in HCT and tolerance induction that were first developed in the canine preclinical model and subsequently applied to human patients are now being recruited into veterinary practice for the treatment of malignant and non‐malignant disorders in companion dogs. Here, we review recent HCT advancements attained in the canine model during the past 15 years.